James J. Kramer, Ph.D., has been appointed vice president, Global Biologics Operations, a newly created position at BioReliance Corp. Dr. Kramer joined the company in December 2007 as vice president, operations, U.S. Biologics. In his new position, his responsibilities will be expanded to include all operations at the company’s three facilities in Scotland, located in Glasgow, Stirling and Edinburgh, Scotland. He will continue to report to president, chief executive officer and chairman David A. Dodd, and will be based at the company’s headquarters in Rockville, MD.

“Jim is an excellent choice to lead our global biologics operations as we aggressively proceed in developing our organization to more effectively serve our clients. His leadership will ensure that BioReliance remains highly competitive as we develop and expand our customer base globally,” said Mr. Dodd. “Since joining the organization, Jim has consistently demonstrated expertise in creating and leading a highly customer-oriented management team. Our focus is to provide the highest levels of client support and service through operational excellence, and I am confident that under Jim’s direction we will achieve that goal.”

Prior to joining BioReliance, Dr. Kramer served as senior vice president/general manager, Talecris Plasma Resources, Talecris Biotherapeutics. Previously, he served as vice president, Global Manufacturing Operations at Serologicals Corporation, and held management positions at Ortho-Clinical Diagnostics, Inc. (a Johnson & Johnson Company), and Pacific Hemostasis Division of Curtin Matheson Scientific.

BioReliance provides biologics safety testing, toxicology, viral manufacturing and laboratory animal diagnostic services.

News from our sister sites